Navigation and Content

By acquiring CRYOPDP, a leading specialty healthcare courier, we’re building on our capabilities in specialized pharma logistics to meet the industry’s evolving needs.

A strategic move

DHL Group has acquired CRYOPDP, a specialized courier service for clinical trials, biopharma, and cell & gene therapies. The move is part of our strategy to become a health logistics leader in the fast-growing life sciences and healthcare (LSH) sector.

Building on a strong foundation

With 30+ years in health logistics, we have built a broad LSH service portfolio backed by over 11,000 LSH specialists. In 2024, our LSH business generated over €5 billion in global revenue. Adding CRYOPDP’s specialty first and last-mile courier services enhances our capabilities and expands our services in specialized pharma logistics.  

In particular, our DHL Supply Chain division will harness CRYOPDP’s expertise to build on its Pharma Specialized Network, which also utilizes the global air capabilities of our DHL Express and DHL Global Forwarding divisions. The network provides a globally integrated solution for delivering end-to-end distribution to clinical sites, laboratories, hospitals, and patients. It is specifically designed for specialty pharmaceuticals and clinical trials that require precise temperature control – ranging from 2-8°C to cryogenic temperatures as low as -150°C. 

Putting on the white gloves

CRYOPDP specializes in “white glove” courier services for time-critical and temperature-sensitive shipments. The services are tailor-made for the LSH sector, which demands utmost care. With operations in 15 countries, the company handles over 600,000 shipments per year, serving customers and patients in over 135 countries worldwide.

DHL Group acquired CRYOPDP from Cryoport, Inc., a global provider of supply chain solutions for the LSH sector. In addition to the deal, we’re forming a strategic partnership with Cryoport to deepen ties between our two companies and leverage each other’s strengths in LSH supply chain services.

Building the DHL Health Logistics brand

The pharmaceutical industry is undergoing a significant transformation, requiring new and improved health logistics. With CRYOPDP now part of the DHL family, we are bolstering our DHL Health Logistics brand with solid solutions for clinical trials, biopharma, and cell & gene therapies. As the needs of the LSH sector continue to evolve, CRYOPDP’s capabilities will help position us as a leader in LSH logistics. 

Explore more!


Published: April 2025
Images: CRYOPDP, DHL


Learn more about DHL Health Logistics

Built on three decades of LSH experience and expertise, our integrated, end-to-end global network spans over 220 countries, ensuring timely delivery of healthcare shipments in the right condition anywhere in the world – all guided by our purpose: #WeCare.


Want it Delivered?

Why go looking for the latest logistics trends and business insights when you can have them delivered right to you?


Related stories